Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 85c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $78.89 -0.48%
Revenue Growth %: +89.8%
Financial Fact:
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES: -19.42M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +89.8%
Financial Fact:
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES: -19.42M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.38), $0.85 worse than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- TNL Mediagene faces Nasdaq delisting over bid price and equity rules
- Deutsche Bank Upgrades Softbank Group Corp. (9984:JP) (SFTBY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
